Page last updated: 2024-08-25

chitosan and leflunomide

chitosan has been researched along with leflunomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Boraie, N; Helmy, MW; Nafee, N; Zewail, M2
Asaad, GF; El-Dakroury, WA; El-Gizawy, SA; Shabana, ME; Zewail, MB1

Other Studies

3 other study(ies) available for chitosan and leflunomide

ArticleYear
Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
    International journal of pharmaceutics, 2019, Aug-15, Volume: 567

    Topics: Administration, Oral; Animals; Arthritis, Rheumatoid; Chitosan; Chondroitin Sulfates; Drug Carriers; Drug Liberation; Immunosuppressive Agents; Joints; Leflunomide; Lipids; Male; Nanostructures; Rats, Sprague-Dawley

2019
Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers.
    Drug delivery and translational research, 2021, Volume: 11, Issue:6

    Topics: Animals; Arthritis, Rheumatoid; Chitosan; Hyaluronic Acid; Hydrogels; Leflunomide; Rats

2021
Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
    International journal of pharmaceutics, 2023, Aug-25, Volume: 643

    Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Chitosan; Clove Oil; Drug-Related Side Effects and Adverse Reactions; Leflunomide; Methotrexate; Rats; Surface-Active Agents; Tumor Necrosis Factor-alpha

2023